ID   CRBG3_HUMAN             Reviewed;        2970 AA.
AC   Q68DQ2; B4DLE8; F6VHI2; Q4G0V8; Q7Z4R9; Q86VD0; Q8N262; Q8N7F1; Q8NDQ8;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   26-NOV-2014, sequence version 3.
DT   03-AUG-2022, entry version 143.
DE   RecName: Full=Very large A-kinase anchor protein;
DE            Short=vlAKAP;
DE   AltName: Full=Beta/gamma crystallin domain-containing protein 3;
GN   Name=CRYBG3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 2455-2970 (ISOFORM 1), NUCLEOTIDE SEQUENCE [LARGE
RP   SCALE MRNA] OF 1-1364 (ISOFORM VLAKAP), AND VARIANT HIS-2874.
RC   TISSUE=Testis, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2238-2970 (ISOFORM 1), AND
RP   VARIANT HIS-2874.
RC   TISSUE=Lymph node, and Rectum tumor;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2650-2970 (ISOFORM 1).
RC   TISSUE=Skin;
RA   Zan Q., Guo J.H., Yu L.;
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2685-2970 (ISOFORM 1), AND
RP   VARIANT HIS-2874.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-931, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   IDENTIFICATION (ISOFORM VLAKAP), FUNCTION (ISOFORM VLAKAP), AND SUBUNIT
RP   (ISOFORM VLAKAP).
RX   PubMed=25097019; DOI=10.1021/bi500721a;
RA   Burgers P.P., van der Heyden M.A., Kok B., Heck A.J., Scholten A.;
RT   "A systematic evaluation of protein kinase A-A-Kinase anchoring protein
RT   interaction motifs.";
RL   Biochemistry 54:11-21(2015).
CC   -!- FUNCTION: [Isoform vlAKAP]: Anchoring protein that mediates the
CC       subcellular compartmentation of protein kinase A (PKA).
CC       {ECO:0000269|PubMed:25097019}.
CC   -!- SUBUNIT: Isoform vlAKAP binds to dimeric RII-alpha regulatory subunit
CC       of PKA (PRKAR2A/PRKAR2B). {ECO:0000269|PubMed:25097019}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=vlAKAP;
CC         IsoId=Q68DQ2-3; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q68DQ2-1; Sequence=VSP_057114;
CC       Name=2;
CC         IsoId=Q68DQ2-2; Sequence=VSP_057115, VSP_057116;
CC   -!- SIMILARITY: Belongs to the beta/gamma-crystallin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH36247.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAP97687.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC03608.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAH18168.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK091199; BAC03608.1; ALT_INIT; mRNA.
DR   EMBL; AK098569; BAC05338.1; -; mRNA.
DR   EMBL; AK296966; BAG59510.1; -; mRNA.
DR   EMBL; AC110491; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL831927; CAD38587.1; -; mRNA.
DR   EMBL; CR749313; CAH18168.1; ALT_FRAME; mRNA.
DR   EMBL; AF451988; AAP97687.1; ALT_INIT; mRNA.
DR   EMBL; BC036247; AAH36247.1; ALT_INIT; mRNA.
DR   EMBL; BC050394; AAH50394.1; -; mRNA.
DR   CCDS; CCDS43113.2; -. [Q68DQ2-3]
DR   RefSeq; NP_705833.3; NM_153605.3. [Q68DQ2-3]
DR   SMR; Q68DQ2; -.
DR   BioGRID; 126284; 51.
DR   IntAct; Q68DQ2; 16.
DR   MINT; Q68DQ2; -.
DR   STRING; 9606.ENSP00000374273; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   GlyGen; Q68DQ2; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q68DQ2; -.
DR   PhosphoSitePlus; Q68DQ2; -.
DR   BioMuta; CRYBG3; -.
DR   DMDM; 172045724; -.
DR   EPD; Q68DQ2; -.
DR   jPOST; Q68DQ2; -.
DR   MassIVE; Q68DQ2; -.
DR   MaxQB; Q68DQ2; -.
DR   PaxDb; Q68DQ2; -.
DR   PeptideAtlas; Q68DQ2; -.
DR   PRIDE; Q68DQ2; -.
DR   ProteomicsDB; 4529; -.
DR   ProteomicsDB; 66095; -. [Q68DQ2-3]
DR   ProteomicsDB; 66096; -. [Q68DQ2-2]
DR   Antibodypedia; 49902; 2 antibodies from 1 providers.
DR   DNASU; 131544; -.
DR   Ensembl; ENST00000389622.7; ENSP00000374273.3; ENSG00000080200.10. [Q68DQ2-3]
DR   GeneID; 131544; -.
DR   KEGG; hsa:131544; -.
DR   MANE-Select; ENST00000389622.7; ENSP00000374273.3; NM_153605.4; NP_705833.3.
DR   UCSC; uc021xbn.3; human. [Q68DQ2-3]
DR   CTD; 131544; -.
DR   DisGeNET; 131544; -.
DR   GeneCards; CRYBG3; -.
DR   HGNC; HGNC:34427; CRYBG3.
DR   HPA; ENSG00000080200; Low tissue specificity.
DR   neXtProt; NX_Q68DQ2; -.
DR   OpenTargets; ENSG00000080200; -.
DR   PharmGKB; PA164718140; -.
DR   VEuPathDB; HostDB:ENSG00000080200; -.
DR   eggNOG; ENOG502QTHR; Eukaryota.
DR   GeneTree; ENSGT00940000160816; -.
DR   HOGENOM; CLU_000811_0_0_1; -.
DR   InParanoid; Q68DQ2; -.
DR   OMA; NSYVMPS; -.
DR   OrthoDB; 89929at2759; -.
DR   TreeFam; TF331078; -.
DR   PathwayCommons; Q68DQ2; -.
DR   SignaLink; Q68DQ2; -.
DR   BioGRID-ORCS; 131544; 0 hits in 246 CRISPR screens.
DR   ChiTaRS; CRYBG3; human.
DR   GenomeRNAi; 131544; -.
DR   Pharos; Q68DQ2; Tdark.
DR   PRO; PR:Q68DQ2; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q68DQ2; protein.
DR   Bgee; ENSG00000080200; Expressed in gingival epithelium and 209 other tissues.
DR   ExpressionAtlas; Q68DQ2; baseline and differential.
DR   Genevisible; Q68DQ2; HS.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0051018; F:protein kinase A binding; IPI:UniProtKB.
DR   GO; GO:0005212; F:structural constituent of eye lens; IBA:GO_Central.
DR   GO; GO:0002088; P:lens development in camera-type eye; IBA:GO_Central.
DR   GO; GO:0007601; P:visual perception; IBA:GO_Central.
DR   CDD; cd00161; RICIN; 1.
DR   InterPro; IPR001064; Beta/gamma_crystallin.
DR   InterPro; IPR011024; G_crystallin-like.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00030; Crystall; 6.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   PRINTS; PR01367; BGCRYSTALLIN.
DR   SMART; SM00458; RICIN; 1.
DR   SMART; SM00247; XTALbg; 6.
DR   SUPFAM; SSF49695; SSF49695; 3.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   PROSITE; PS50915; CRYSTALLIN_BETA_GAMMA; 9.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Lectin; Phosphoprotein; Reference proteome; Repeat.
FT   CHAIN           1..2970
FT                   /note="Very large A-kinase anchor protein"
FT                   /id="PRO_0000325758"
FT   DOMAIN          2334..2383
FT                   /note="Beta/gamma crystallin 'Greek key' 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          2429..2467
FT                   /note="Beta/gamma crystallin 'Greek key' 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          2479..2523
FT                   /note="Beta/gamma crystallin 'Greek key' 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          2524..2566
FT                   /note="Beta/gamma crystallin 'Greek key' 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          2572..2613
FT                   /note="Beta/gamma crystallin 'Greek key' 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          2614..2656
FT                   /note="Beta/gamma crystallin 'Greek key' 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          2667..2703
FT                   /note="Beta/gamma crystallin 'Greek key' 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          2704..2746
FT                   /note="Beta/gamma crystallin 'Greek key' 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          2793..2834
FT                   /note="Beta/gamma crystallin 'Greek key' 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          2836..2968
FT                   /note="Ricin B-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   REGION          1..117
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          134..229
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          254..274
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          294..322
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          341..370
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          427..461
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          529..549
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1299..1322
FT                   /note="RII-binding helix"
FT                   /evidence="ECO:0000269|PubMed:25097019"
FT   REGION          2095..2124
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2139..2163
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        22..37
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        51..71
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        72..91
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        141..176
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        177..216
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        254..270
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        435..461
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         931
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         2086
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80W49"
FT   MOD_RES         2093
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80W49"
FT   MOD_RES         2094
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80W49"
FT   MOD_RES         2100
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80W49"
FT   MOD_RES         2104
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80W49"
FT   VAR_SEQ         1..2742
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_057115"
FT   VAR_SEQ         1..1948
FT                   /note="Missing (in isoform 1)"
FT                   /id="VSP_057114"
FT   VAR_SEQ         2743..2747
FT                   /note="KPIDY -> MNKKK (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_057116"
FT   VARIANT         2381
FT                   /note="R -> H (in dbSNP:rs11918990)"
FT                   /id="VAR_039906"
FT   VARIANT         2709
FT                   /note="Y -> C (in dbSNP:rs17302349)"
FT                   /id="VAR_039907"
FT   VARIANT         2874
FT                   /note="N -> H (in dbSNP:rs4857302)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005"
FT                   /id="VAR_039908"
FT   CONFLICT        2693
FT                   /note="S -> P (in Ref. 3; CAH18168)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2765
FT                   /note="R -> G (in Ref. 5; AAH36247)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2768..2771
FT                   /note="Missing (in Ref. 4; AAP97687)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2847
FT                   /note="Q -> R (in Ref. 5; AAH50394)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2970 AA;  330633 MW;  A0851F4BC1252D1E CRC64;
     MSSGRRRGSA PWHSFSRFFA PRSPSRDKEE EEEERPGTSP PPAPGRSAAS VENEPMSTSQ
     KKENVLSSEA VKIRQSEDKR NHAEKPVTLP VQEDPKKAYD LSSSTSDTKI GESDRQPKES
     FFQFLGNLFN ISGKSSLGEA KQSSFKDDQD KTEKDLQNPS DHHEDGIKRE REIFSGSLRT
     QTHPTEEQDS NSSELSDAFS LDTTQDSDQE TTNLLKQIDG KPEKPSVTYA TYRGPRHIGK
     YLKQQTGLAT VNTLDRENES SDSSTNRHID PGSEIEAGVL PLLLSASTDS SMKGNLLEGP
     LEDSDCSKTS FNKENSLTNN PELQNIASSN NLLNKNAWGS IERNRSSPSS VTNSSYDGES
     DSQHHLSCEP VSQTNRNLVC SALLTGSNHR KVPCSPDFQR VTTTENTIKE NSTVMSNRTL
     VQREELVEPQ GPAISDFSCS KSDGSDTTEQ ESTNLPSPNK SIRHEHLQLP ESECSDKQTI
     DSSSKQAATH TNIIALQRHA VTDTEFVNEG KRLSAQDSQK NVAVREIRRE TESASAGESI
     ASSHVKAPED KIESLPKDTD QYFETKAKKL DFRSHDKIPH IRMNKKDLAS LNYISESAVV
     ASLGNENAPE LKFELNRSHI SETPLDSESP QQAEVSPDAK TSLSLDCKKL NFSISPPTFV
     SGVGMLSKLD IPDLMNEGSP VPIETGNVNI VGISYQPRKC KEENVKNHVE AAGRKSPPPS
     FCLEYTSAIF EFKEVLSNSE KCQVLPGSEA SGPHLTGLEL LSFDSGNLSK DCSSILSQDP
     NRVELVSSNT KANMSIIEKS DSLSLEAKTA NIVSKAEIDG QNNVLVESHS GRGKTISLSK
     VSLSKVEPRN ISQDKMSSFP LKITHVPEKP ILSELTFLEV EQGKRFQSIN HNEIGEKCSD
     AGLKENCQAE LSPAASKYED KPEPEVDALG SPPALLKSNI SWILPPIHDE KISRQMAQNC
     EAHTCVFHQS LDICGTKKIS GHSEMAELSL TNISPKFQET GSMKVNSPFL DSDSSLEKNS
     SASEDSSFLK VPSVLKLEKK SSSYRKKENI HFLNGGIDSV SSSSSYPEEV SMIVNSHKPQ
     NNLDSIQVTK DLTHEGTSVT NLLYPTTSYL EFETSVSIGT EVTPFQEHFG IYTGKISIDF
     PTAAQFDNLV EAETGAVAGP AASVNSSGQQ CSEASAEHIE ARRRAHDQLL DLKSSLLKKA
     DTLIGEIFNS VREELKFKHT VSTCQEHIAI EGIMNLGTLK EDISEKNPSE VTLTEIQQTE
     GLEEQGMENM SEVKEKPCVS PTVGEKNLLV DPNSMNVSCL LEDKARELVN EIIYVAQEKL
     RNDTFEDTED TWDSELQANT SKILNSDSVK PHDVVREFLV SEQPVNQSTQ ISENKVLNEF
     FSLSNLASGT ESIKGGEIVL YQKSLFSGNG SGLSDSINLQ ESDTVLLAED MSHKRLDDRV
     KTHLFRSEDC NETMEIENVD NNKTETEDRR TLVLNFKWPP LVNDDIHAPG TSKSSLSDSL
     VCISEKNLPG HSKNTPLAMS DVGKVHKKDN EINIGKIELI PSMLETGKTN KKDAELNILK
     YEAVPPMIEM GRIHKMDAEL NVTKTEPKAN VFKMGEVYQM DAESCIEKTE GSAVILGMEK
     AYKMKDTEGD IGKIEVIPMM PEVKNIHQKD AEGDIVKTEM TPVTVDMENI YQTHAEGDIG
     KTGTIALSEV ENIHQKGGEG ISEKAEVIPV TLAMENTYQK DAEGDIGKAE VMPVRLEMEN
     TYPKDTERDG GKTEVMPLAL EVVNTYQKNA KGFTGNTEGS VLKMEATYRK TAEEVIKNTE
     IVPCVLKVKE AHETAPAPLE MEKACKRDVK ETIGATVSTP SVIEMEKISP EDRGENIGKH
     KVLPAVVDIE KIHGTGLELT TKQGEAMLPA FESKTPQEYA EGSVEETKEE PTEIKEGLIA
     HENRLPTYFR GYESPTLSKD YEGYPAPAMP DFQPGDTTVR LDKRMSLTAI YDKRRETDYS
     DKGYNLAFVS QDEQENSSFT ILYEEPLQEE DKYASAEARQ TQSVLFHDTS ADSMPVLACE
     RSESRTDLVH HFEKGTKLGE TFDSDSSEMF LSVEAKRYKI YPLALSPIYE DDSSQEDILS
     SEVSPGHHGP RKSRDSENQS SSVLSLLQSV SERLKMNFDE DDREAADEEE EEEEAAVLHK
     GDLRAGSGER VTFQLPDPSI TFYPDDQESV GISKNSYVMP NEPTTSNLQV GLWPEKTSFL
     QKSDLTSKLH SSLKSAYHQY LQTSQSHSSE KGARFGGIFQ EPVSKYFRVQ DSPGRLSPFI
     ENVDKQTLRC NPRPGKMVIY DLHESTYKQE VYCNIPDATS WSFPNGVLIK VVRGCWILYE
     KPHFRGQKCV LEEGEKVLNR DWILQNRRHP QRNFILGSLK RVLKDCSIPE IELFPQSDPA
     CCPVYIQRAV PNLEELNISK SVSFTVKSGV WLAYPDINFK GQATVLEEDH GLFEISTAEM
     KSLHPLQMGG LKVEMPMNLK VIIYEKPHFH GQAKEFSEHI DSVPNFLKNN GDFHRIGSIR
     VIGGVWVAYE KEHFKGQQFL LEEGDFEDSN ACGALSSPIL SFRYLQANFI ESSVTLFESD
     LESGKFIDIT NQEISDLEEI GFGSKTRSIH VKSGVWVAYQ QKFFCGEQYI LEKGKYKCFF
     DWGGSNNIIM SIRPIQLEPL GINEPPHLLK AFSKPGFQGE CIDFTEETSD LTSLMPCSFK
     VLRGCWLLYY QEDMFVNHCV LEEGLYADLT SCGCPASKVK SLKPIDYVFE EPSISLFALE
     HCEGRELHLE EAVNSVLNKD LHFYTQSVWV KSGLWIAYEG SNFLGRQILL RPNEIPNWTA
     FSRWKTIGSL RPMKQPAVYI RIKNRAQGEY LTVTGSLADT RATSVCISPY SGKNTQIWYY
     CRGLFKSKAS DTCLDVIGGR DTPGAKVALW TEHGQFRQKW RLNKNGTISS YLSDQLVLDV
     KGGNYCDKTH VIVNQPLEGE ETQKWDIEIL
//
